Skip to main content
. 2026 Jun 21;17(6):718. doi: 10.3390/genes17060718
ANOVA analysis of variance
AS activity score
CD dose-corrected serum concentration
CPIC Clinical Pharmacogenetics Implementation Consortium
CPR creatinine production rate
CYP cytochrome P450 enzymes
FFM fat-free mass
IM intermediate metabolizers
MPR metabolite-to-parent ratio
NM normal metabolizers
PM poor metabolizers
RM rapid metabolizers
TDM therapeutic drug monitoring
UM ultrarapid metabolizers